중독 치료 시장 : 현황 분석 및 예측(2022-2030년)

Addiction treatment refers to a range of interventions and therapies designed to help individuals overcome addiction and substance abuse disorders. Treatment options may include medical interventions, behavioral therapies, counseling, and support groups. The goal of addiction treatment is to help individuals break free from the cycle of addiction and develop the skills and strategies necessary to maintain long-term recovery. Treatment programs may be tailored to address the specific needs of the individual, taking into account factors such as the severity of the addiction, co-occurring mental health conditions, and personal preferences. Effective addiction treatment typically involves a combination of therapies and support services, as well as ongoing monitoring and follow-up care to support long-term recovery.

The addiction treatment market is expected to grow at a steady rate of around 6% owing to the increasing prevalence of addiction and substance abuse disorders. Moreover, advancements in medical technology and the development of new treatment methods, increased public awareness of addiction, and efforts to reduce the associated with seeking treatment have also contributed to the growth of the market. For instance, Texas Health and Human Services launched a $23.2 million public awareness campaign in March 2022 to help people get access to addiction treatment and services and prevent substance abuse disorders.

Based on treatment type, the market is segmented into alcohol addiction treatment, tobacco treatment, opioid treatment, and others. Among these, the alcohol addiction treatment category is to witness a higher CAGR during the forecast period. This is mainly due to its high consumption and the large number of people addicted to alcohol. For instance, as per CDC, around 17% of the population are binge alcohol drinkers in the U.S., and 6% are exposed to heavy drinking.

On the basis of treatment centers, the market is categorized into inpatient centers, residential centers, rehabilitation centers, and others. Among these, the inpatient centers held a significant share of the market in 2021. This is mainly due to these centers providing a safe and structured environment for individuals to detox from drugs or alcohol under the supervision of medical professionals. This can be crucial for individuals who are physically dependent on a substance, as withdrawal symptoms can be severe and even life-threatening in some cases.

Based on the distribution channel, the addiction treatment market has been classified into hospital pharmacies, medical stores, and others. The hospital pharmacies category is to witness higher adoption of addiction treatment during the forecast period. This is mainly due to the availability of a variety of services & products to help patients overcome addiction. Also, the demand for addiction treatment continues to grow because of hospital pharmacies will be well-positioned to meet the needs of patients and contribute to the growth of this segment.

For a better understanding of the market adoption of the addiction treatment industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. This is mainly due to the growing prevalence of addiction and substance abuse disorders, along with the rising awareness of the need for effective treatment options. The region has a well-established healthcare system and access to advanced medical technology, which has led to the development of new and innovative treatment methods. Additionally, the government has taken initiatives to increase funding for research and development in the field, further contributing to the market growth.

Some of the major players operating in the market include: Cipla Inc., Alkermes, Pfizer Inc., Orexo AB, GSK plc., Sandoz International GmbH, Reckitt Benckiser Group PLC, Teva Pharmaceutical Industries Ltd., Novartis AG, and Indivior PLC

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Addiction Treatment Market
• 2.2. Research Methodology of the Addiction Treatment Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE ADDICTION TREATMENT MARKET

6 ADDICTION TREATMENT MARKET REVENUE, 2020-2030F

7 MARKET INSIGHTS BY TREATMENT TYPE

• 7.1. Alcohol Addiction Treatment
• 7.2. Tobacco Treatment
• 7.3. Opioid Treatment
• 7.4. Others

8 MARKET INSIGHTS BY TREATMENT CENTERS

• 8.1. Inpatient Centers
• 8.2. Residential Centers
• 8.3. Rehabilitation Centers
• 8.4. Others

9 MARKET INSIGHTS BY DISTRIBUTION CHANNEL

• 9.1. Hospital Pharmacies
• 9.2. Medical Stores
• 9.3. Others

10 MARKET INSIGHTS BY REGION

• 10.1. North America
  • 10.1.1. U.S.
  • 10.1.2. Canada
  • 10.1.3. Rest of North America
• 10.2. Europe
  • 10.2.1. Germany
  • 10.2.2. U.K.
  • 10.2.3. France
  • 10.2.4. Italy
  • 10.2.5. Spain
  • 10.2.6. Rest of Europe
• 10.3. Asia-Pacific
  • 10.3.1. China
  • 10.3.2. Japan
  • 10.3.3. India
  • 10.3.4. Rest of Asia-Pacific
• 10.4. Rest of World

11 ADDICTION TREATMENT MARKET DYNAMICS

• 11.1. Market Drivers
• 11.2. Market Challenges
• 11.3. Impact Analysis

12 ADDICTION TREATMENT MARKET OPPORTUNITIES

13 ADDICTION TREATMENT MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

• 14.1. Demand Side Analysis
• 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 PRICING ANALYSIS

17 STRATEGIC INSIGHTS

18 COMPETITIVE SCENARIO

• 18.1. Competitive Landscape
  • 18.1.1. Porters Fiver Forces Analysis

19 COMPANY PROFILED

• 19.1. Cipla Inc.
• 19.2. Alkermes
• 19.3. Pfizer Inc.
• 19.4. Orexo AB
• 19.5. GSK plc.
• 19.6. Sandoz International GmbH
• 19.7. Reckitt Benckiser Group PLC
• 19.8. Teva Pharmaceutical Industries Ltd.
• 19.9. Novartis AG
• 19.10. Indivior PLC

20 DISCLAIMER